HCP info about RITUXAN® (rituximab) treatment for RA, NHL, CLL, GPA, MPA and PV including safety information, dosing, efficacy and support. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more infor
包括高危疾病患者。来自CAPTIVATE研究的最新数据强调,全口服固定疗程Imbruvica+Venclexta方案治疗,在使患者获得无治疗缓解(treatment-free remission,TFR)的同时,也能在2年内获得高无进展生存率。”
原文出处:New Data from Phase 3 GLOW Study Show Fixed-Duration Treatment with IMBRUVICA (ibrutinib) Plus Venetoclax Demonstrated Deeper and Sustained Undetectable Minimal Residual Disease Outcomes in First-Line Chronic Lymphocytic Leukemia
An expert on CLL/SLL provides clinical insights on approaching the treatment of patients who progress beyond initial therapy. EP: 1.Clinical Approaches in High-Risk Patients with CLL/SLL EP: 2.SEQUOIA Arm D Study: Zanubrutinib plus Venetoclax in T...
Apple Vision Requires visionOS 1.0 or later. Languages English Age Rating 17+ Unrestricted Web Access Infrequent/Mild Medical/Treatment Information Copyright © 2025 Copyright @Point of Care™. All rights reserved. Price Free Developer Website App Support Privacy Policy More...
What's most important to me when I'm evaluating a patient is that they, number one, tolerate the therapy, and number two, that their symptoms that they were experiencing prior to starting treatment have resolved. At some point during your treatment, whether you're on chronic oral therapy ...
CLL14 treated patients for 1 year, and then all patients stopped treatment regardless of some MRD [minimal residual disease] or response, and stopped therapy at that point in time. And 5 years later, 64% of patients are progression free. I think the overall survival [OS] is measured still...
Requires visionOS 1.0 or later. Languages English Age Rating 17+Unrestricted Web AccessInfrequent/Mild Medical/Treatment Information Copyright © 2025 Copyright @Point of Care™. All rights reserved. Price Free Developer Website App Support Privacy Policy...
COPIKTRA is an oral treatment option for relapsed CLL/SLL. See Important Safety Info and Medication Guide for information on serious side effects.
COPIKTRA is an oral treatment option for relapsed CLL/SLL. See Important Safety Info and Medication Guide for information on serious side effects.